Read Drug Approval Update Specialty New drugs 04/22/2024 Anktiva® (nogapendekin alfa inbakicept-pmln) The FDA approved Anktiva for use in combination with Bacillus Calmette-Guérin (BCG) for the...

Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model

Studies on GLP-1 drugs, specialty therapies and more help improve affordability in health care

New data reveal sharp growth in Ozempic prescribing across the country, reflecting the rising demand for GLP-1 therapies